Search News

Corporate Industry Technology Medical Updates

heart failure

Medical Updates
Percutaneous Ventricular Assist Device jointly developed by Ge Junbo’s team of Zhongshan Hospital affiliated to Fudan university and magAssist has made ground-breaking achievements 2021-07-17
Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference 2021-07-16
Technology
The Organ Care System jointly developed by Wuhan Union Hospital and magAssist has ushered in a breakthrough 2021-07-05
Medical Updates
Big country Great Medic｜Nianguo Dong's team, pioneer of heart transplantation in China 2021-06-09
Medical Updates
The Surgical Team of Guangdong Provincial People's Hospital Completed the Preclinical Training on Extracorporeal Ventricular Assist System 2020-12-21
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-09-05
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,